| 西罗莫司抗肿瘤研究的进展 |
| |
| 引用本文： | 董济民,慕为民.西罗莫司抗肿瘤研究的进展[J].湖南中医药大学学报,2009,29(8):65-67. |
| |
| 作者姓名： | 董济民 慕为民 |
| |
| 作者单位： | 西安市中心医院肿瘤科,陕西,西安,710003 |
| |
| 摘 要： | 西罗莫司（Sirolomus）原称雷帕霉素（Rapamycin，RPM），是新型强效亲脂性三烯含氮大环内酯抗生素类免疫抑制剂。它在抗移植排斥反应、预防支架植入术后再狭窄等方面均有作用。近年来发现它在抗肿瘤方面有重要作用。本文主要介绍了西罗英司的抗肿瘤作用机制及其应用的研究进展。
|
| 关 键 词： | 西罗莫司 免疫抑制剂 抗肿瘤 研究进展 |
Sirolimus treated anti-tumor current reseach progress |
| |
| DONG Gi-min,MU Wei-min.Sirolimus treated anti-tumor current reseach progress[J].Journal of Traditional Chinese Medicine University of Hunan,2009,29(8):65-67. |
| |
| Authors: | DONG Gi-min MU Wei-min |
| |
| Institution: | (Central Hospital ofXi an,Shaanxi,710003, China) |
| |
| Abstract: | sirolimus （Sirolomus） formerly known as rapamycin （Rapamycin, RPM）, is a new potent lipophilic nitrogen triene macrolide immunosuppressant antibiotics. Its anti-transplant rejection, prevention restenosis after stent implantation, such as the role of aspects. In recent years, found it in the anti-tumor has an important role. This paper mainly introduces the sirolimus mechanism of anti-tumor research and its applications. |
| |
| Keywords: | Sirolimus immtmosuppressant anti-tumor Progress |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
